недоступно на русском языке

Тезис Предпросмотр

This document specifies general requirements for tissue-engineered medical products (TEMPs), which are used in regenerative medicine. With regard to safety, this document outlines requirements for materials, manufacture, quality control, and unintentional biological effects elicited by TEMPs. This document does not address requirements for clinical trials and efficacy.

This document is not applicable to tissue-engineered products used for diagnosis, ex-vivo testing or extracorporeal treatments of patients (e.g. dialysis with TEMP components). TEMPs containing viable xenogenic cells, genetically modified cells, or cells derived from abnormal cells or tissues (e.g. cancerous tissues) are also excluded from the scope. The combination of TEMPs with medical devices, with the exception of scaffolds comprised of synthetic and/or naturally-derived (e.g. animal sourced) materials, is also excluded from the scope.

NOTE International, national or regional regulations or requirements, or the Pharmacopeia also apply to specific topics covered in this document.


Общая информация

  • Текущий статус :  Published
    Дата публикации : 2020-08
  • Версия : 1
  • :
    ISO/TC 150/SC 7
    Tissue-engineered medical products
  • 11.040.40
    Implants for surgery, prosthetics and orthotics

Приобрести данный стандарт

Формат Язык
PDF + ePub
Бумажный
  • CHF58

Жизненный цикл

Стандарт, который пересматривается каждые 5 лет



Изменения / Исправления

  • Сейчас
    ISO/TS 21560:2020

Появились вопросы?

Ознакомьтесь с FAQ

Работа с клиентами
+41 22 749 08 88

Часы работы:
Понедельник – пятница: 09:00-12:00, 14:00-17:00 (UTC+1)

Будьте в курсе актуальных новостей ИСО

Подписывайтесь на наши новости, обзоры, а также на информацию о продуктах.